Registry of Patients That Have Undergone ICA or PCI

Registry of Patients That Have Undergone an Invasive Coronary Angiography and/or Percutaneous Coronary Intervention

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04815928

Acronym

ICA-PI

Enrollment

10000

Registered

2021-03-25

Start date

2020-07-01

Completion date

2035-07-01

Last updated

2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Quantiative Flow Ratio, QFR, Fractional Flow Reserve, FFR, Instantaneous wave-free ratio, iFR, Invasive Coronary Angiography, Percutaneous Coronary Intervention

Brief summary

In Invasive Coronary Angiography there are multiple invasively obtained measurements to determine the funcitonal significance of Cornary Artery Disease. In this Registry, patients who have undergone Invasive Coronary Angiography or Percutaneous Coronary Intervention are included to investigate diagnostic and prognostic implications of the invasive measurements.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years * Has undergone or will undergo a clinically indicated invasive coronary angiography. * Has undergone or will undergo a clinically indicated percutaneous coronary intervention.

Exclusion criteria

* Not willing / unable to provide informed consent.

Design outcomes

Primary

Measure	Time frame	Description
Fractional Flow Reserve (FFR)	Upon inclusion at index procedure	Invasively obtained FFR
Instantaneous wave-free ratio (iFR)	Upon inclusion at index procedure	Invasively obtained iFR
Quantitative Flow Ratio (QFR)	Upon inclusion at index procedure	Invasively obtained QFR
Stenosis percentage	Upon inclusion at index procedure	Invasively obtained stenosis percentage

Secondary

Measure	Time frame	Description
Major adverse cardiac events, cardiac death or repeat revascularization	5 years	The secondary endpoint is to assess the prognostic value of the obtained parameters.

Countries

Netherlands

Outcome results